Jonathan Backer - Concepedia

Author

Jonathan Backer

Albert Einstein College of Medicine ORCID

Also Known As

A Van Alphen, Arkel Van, Huang, Huey-Lan, J M Backer, J Verkade, J. Backer, J. M. Backer, J.M. Backer, JONATHAN M. BACKER, Jonathan Backer

215

Publications

31K

Citations

H-Index

107

Concepts

All Affiliations

Albert Einstein College of Medicine Joslin Diabetes Center Harvard University Brigham and Women's Hospital Yeshiva University

About

Jonathan Backer is an author at Albert Einstein College of Medicine specializing in medicine, cell signaling, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	53	74	13.2K
2	Natural Sciences	33	37	7.9K
3	Health Sciences	5	5	867
4	Engineering	2	2	275
5	Education	1	1	50

Jonathan Backer

130

Publications

28.4K

Citations

H-Index

Page 1

	Year	Citations
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Daniel J. Klionsky, Kotb Abdelmohsen, Akihisa Abe, Autophagy	2016	5.9K
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup> Daniel J. Klionsky, Amal Kamal Abdel‐Aziz, Sara Abdelfatah, Autophagy	2021	2.5K
Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein Xiao‐Jian Sun, Paul Rothenberg, C. Ronald Kahn, Nature Signal TransductionMolecular PhysiologyBiochemistryG Protein-coupled ReceptorNatural Sciences	1991	1.6K
Phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. Jonathan Backer, Martin G. Myers, Steven E. Shoelson, The EMBO Journal Molecular PharmacologyInsulin SignalingMolecular PhysiologySignal TransductionBiochemistry	1992	1K
Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase Takahiro Nobukuni, Manel Joaquin, Marta Roccio, Proceedings of the National Academy of Sciences Class 3Amino AcidsMolecular RegulationMetabolic RemodelingInsulin Signaling	2005	747
The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. E. Y. Skolnik, Chi‐Hon Lee, Andreas Batzer, The EMBO Journal Insulin ControlInsulin SignalingMolecular PhysiologySignal TransductionSignaling Pathway	1993	706
Phosphatidylinositol-3-OH kinases are Rab5 effectors Savvas Christoforidis, Marta Miączyńska, Keith Ashman, Nature Cell Biology Signal TransductionSignaling PathwayReceptor Tyrosine KinaseRab5 EffectorsMedicine	1999	623
Role of phosphatidylinositol 3-kinase and Rab5 effectors in phagosomal biogenesis and mycobacterial phagosome maturation arrest Rutilio A. Fratti, Jonathan Backer, Jean Grüenberg, The Journal of Cell Biology	2001	533
Distinct roles of class I and class III phosphatidylinositol 3-kinases in phagosome formation and maturation Otília V. Vieira, Roberto J. Botelho, Lucia E. Rameh, The Journal of Cell Biology	2001	524
Regulation of the p85/p110 Phosphatidylinositol 3′-Kinase: Stabilization and Inhibition of the p110α Catalytic Subunit by the p85 Regulatory Subunit Jinghua Yu, Yitao Zhang, James McIlroy, Molecular and Cellular Biology	1998	522

Page 1